S Karam, A Kaushal, NA Amer, V Royal… - Advances in Kidney …, 2024 - Elsevier
Highlights•Non-immunoglobulin (Ig) amyloidosis represents a significant portion of amyloidosis-mediated kidney disease.•Serum amyloid A amyloidosis and leukocyte …
Chronic kidney disease is a really important heath issue, and transplantation is an intervention that can greatly increase patient quality of life and survival. The aim of this study …
J Yamauchi, D Raghavan, D Jweehan, S Oygen… - …, 2024 - journals.lww.com
Background. We aimed to assess contemporary transplant outcomes among kidney recipients with amyloidosis, as the treatment and prognosis of amyloidosis have shown …
HJ Lachmann - Journal of the American Society of Nephrology, 2024 - journals.lww.com
AA amyloidosis is the most serious kidney complication of chronic inflammation and is characterized by the deposition of fibrils derived from misfolded serum amyloid A (SAA) …
S Georgin-Lavialle, G Grateau - Annales de Pathologie, 2024 - Elsevier
Résumé Les trois variétés les plus fréquentes d'amyloses systémiques sont les amyloses à transthyrétine (ATTR), l'amylose immunoglobulinique (AL) et l'amylose inflammatoire (AA). Il …
Die Amyloidosen sind eine Gruppe von seltenen Erkrankungen, die sich durch die Bildung und Ablagerung von aberrant gefalteten Proteinen definieren. Grundsätzlich können sowohl …
Background: Familial Mediterranean fever (FMF) is a hereditary autoinflammatory disorder commonly found in populations from the Mediterranean region, including Turks, Armenians …
Favorable Outcomes following Kidney Transplant in Patients with AA Amyloidosis Page 1 10 | ASN Kidney News | March 2024 Favorable Outcomes following Kidney Transplant in Patients …